MORIHITO OKADA

Last Updated :2021/04/05

Affiliations, Positions
Research Institute for Radiation Biology and Medicine, Professor
E-mail
morihito1217gmail.com

Basic Information

Academic Degrees

  • Doctor of Philosophy in Medical Science, Kobe University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Respiratory surgery

Educational Activity

Course in Charge

  1. 2021, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2021, Undergraduate Education, Intensive, Practice for medical research
  3. 2021, Liberal Arts Education Program1, 1Term, Introductory Seminar for First-Year Students
  4. 2021, Graduate Education (Doctoral Program) , First Semester, Principles of Oncology
  5. 2021, Graduate Education (Doctoral Program) , First Semester, Advanced research on Surgical Oncology
  6. 2021, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Surgical Oncology
  7. 2021, Graduate Education (Doctoral Program) , 1Term, Principles of Oncology
  8. 2021, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Surgical Oncology
  9. 2021, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Surgical Oncology
  10. 2021, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Surgical Oncology
  11. 2021, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Surgical Oncology
  12. 2021, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Breast Cancer Treatment
  13. 2021, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Breast Cancer Treatment
  14. 2021, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Surgical Oncology
  15. 2021, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Surgical Oncology

Research Activities

Academic Papers

  1. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 143(3), 607-612, MAR 2012
    Link to Paper Search Results by DOI
  2. Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil, ONCOLOGY REPORTS, 29(3), 925-931, MAR 2013
    Link to Paper Search Results by DOI
  3. Esophageal Bypass Operation Prior to Definitive Chemoradiotherapy in Advanced Esophageal Cancer With Tracheobronchial Invasion, ANNALS OF THORACIC SURGERY, 97(1), 290-295, JAN 2014
    Link to Paper Search Results by DOI
  4. Emergency escape surgery for a gastro-bronchial fistula with respiratory failure that developed after esophagectomy, Surgery Today, 45(3), 369-373, MAR 2015
    Link to Paper Search Results by DOI
  5. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer, DISEASES OF THE ESOPHAGUS, 28(4), 358-364, MAY-JUN 2015
    Link to Paper Search Results by DOI
  6. Utility of F-18 FDG-PET/CT for predicting prognosis of luminal-type breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 150(1), 209-217, FEB 2015
    Link to Paper Search Results by DOI
  7. Comparison of Malignant Grade Between Pure and Partially Invasive Types of Early Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 99(3), 956-960, MAR 2015
    Link to Paper Search Results by DOI
  8. The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial, CLINICAL BREAST CANCER, 15(2), 110-116, APR 2015
    Link to Paper Search Results by DOI
  9. The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling, NATURE CELL BIOLOGY, 17(1), 81-+, JAN 2015
    Link to Paper Search Results by DOI
  10. Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection, ANNALS OF THORACIC SURGERY, 99(5), 1746-1754, MAY 2015
    Link to Paper Search Results by DOI
  11. Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 149(4), 982-988, APR 2015
    Link to Paper Search Results by DOI
  12. What are the radiologic findings predictive of indolent lung adenocarcinoma?, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45(4), 367-372, APR 2015
    Link to Paper Search Results by DOI
  13. Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 47(4), 648-652, APR 2015
    Link to Paper Search Results by DOI
  14. Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 47(6), 1022-1026, JUN 2015
    Link to Paper Search Results by DOI
  15. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99(6), 1887-1893, JUN 2015
    Link to Paper Search Results by DOI
  16. Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia, RESPIRATORY RESEARCH, 16, AUG 1 2015
    Link to Paper Search Results by DOI
  17. The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis, JOURNAL OF BIOMEDICAL SCIENCE, 22, AUG 11 2015
    Link to Paper Search Results by DOI
  18. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45(8), 767-773, AUG 2015
    Link to Paper Search Results by DOI
  19. Randomized phase II study of adjuvant chemotherapy with long-term S-1 versus cisplatin+S-1 in completely resected stage II-IIIA non-small cell lung cancer., Clinical cancer research, 2015 AUG 7
  20. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma., Lung Cancer, 90(2), 199-204, 2015 NOV
  21. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer, CANCER MEDICINE, 4(10), 1536-1546, OCT 2015
    Link to Paper Search Results by DOI
  22. The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT, RESPIRATION, 90(4), 293-298, 2015
    Link to Paper Search Results by DOI
  23. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma, LUNG CANCER, 90(2), 199-204, NOV 2015
    Link to Paper Search Results by DOI
  24. Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer, CLINICAL CANCER RESEARCH, 21(23), 5245-5252, DEC 1 2015
    Link to Paper Search Results by DOI
  25. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 100(6), 2079-2086, DEC 2015
    Link to Paper Search Results by DOI
  26. Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema, ANNALS OF SURGICAL ONCOLOGY, 22, S1371-S1379, DEC 2015
    Link to Paper Search Results by DOI
  27. Association between [F-18]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1 alpha and glucose transporter 1 in non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45(12), 1154-1161, DEC 2015
    Link to Paper Search Results by DOI
  28. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 49(1), 293-299, JAN 2016
    Link to Paper Search Results by DOI
  29. Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia, PATHOBIOLOGY, 83(1), 33-40, 2016
    Link to Paper Search Results by DOI
  30. Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial, CANCER, 122(7), 1050-1059, APR 1 2016
    Link to Paper Search Results by DOI
  31. Surgical Resection of Thoracic Esophageal Cancer with Interstitial Lung Disease: A Case Report., Hiroshima journal of medical sciences, 65(1), 19-23
  32. Completion lobectomy after radical segmentectomy for pulmonary malignancies., Asian cardiovascular & thoracic annals, 24(5), 450-454

Publications such as books

  1. 2012, Illustrated Anatomical Segmentectomy for Lung Cancer, Nomori,Hiroaki Okada,Morihito

Social Activities

History as Peer Reviews of Academic Papers

  1. Journal of Clinical Oncology
  2. Journal of Thoracic and Cardiovascular Surgery
  3. Chest
  4. Annals of Thoracic Surgery
  5. European Journal of Cardiothoracic Surgery
  6. Lung Cancer
  7. Journal of Thoracic Oncology
  8. Surgery Today
  9. Cancer Science
  10. Japanese Journal of Clinical Oncology, Editor
  11. General Thoracic and Cardiovascular Surgery, Editor